Literature DB >> 24018760

Fundoplication versus medical management of gastroesophageal reflux disease: systematic review and meta-analysis.

Nadja Rickenbacher1, Thomas Kötter, Michael M Kochen, Martin Scherer, Eva Blozik.   

Abstract

BACKGROUND: Medical, endoscopic, and open/laparoscopic surgical methods are used to treat gastroesophageal reflux disease (GERD). This study aimed to perform a systematic review of randomized controlled trials comparing medical and surgical treatments of GERD in adult patients.
METHODS: For the study, MEDLINE and EMBASE (1980-2012) were searched. Two reviewers independently assessed methodologic aspects and extracted data from eligible studies, focusing on patient-relevant outcomes. The primary outcomes were health-related and GERD-specific quality-of-life aspects. Standardized mean differences (SMDs) between treatment groups were calculated and combined using random-effect meta-analysis.
RESULTS: The study identified 11 publications reporting on 7 trials comparing surgical (open or laparoscopic) and medical treatment of GERD. Meta-analysis of both quality-of-life aspects showed a pooled-effect estimate in favor of fundoplication (SMD 0.18; 95 % confidence interval [CI] 0.01-0.35; SMD 0.33; 95 % CI 0.13-0.54). Heartburn and regurgitation were less frequent after surgical intervention. However, a considerable proportion of patients still needed antireflux medication after fundoplication. Nevertheless, the surgical patients were significantly more satisfied with their symptom control and showed higher satisfaction with the treatment received.
CONCLUSIONS: This systematic review showed that surgical management of GERD is more effective than medical management with respect to patient-relevant outcomes in the short and medium term. However, long-term studies still are needed to determine whether antireflux surgery is an equivalent alternative to lifelong medical treatment.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24018760     DOI: 10.1007/s00464-013-3140-z

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  30 in total

1.  Proton pump inhibitor use, hip fracture, and change in bone mineral density in postmenopausal women: results from the Women's Health Initiative.

Authors:  Shelly L Gray; Andrea Z LaCroix; Joseph Larson; John Robbins; Jane A Cauley; JoAnn E Manson; Zhao Chen
Journal:  Arch Intern Med       Date:  2010-05-10

2.  A randomized controlled trial of laparoscopic Nissen fundoplication versus proton pump inhibitors for the treatment of patients with chronic gastroesophageal reflux disease (GERD): 3-year outcomes.

Authors:  Mehran Anvari; Christopher Allen; John Marshall; David Armstrong; Ron Goeree; Wendy Ungar; Charles Goldsmith
Journal:  Surg Endosc       Date:  2011-04-22       Impact factor: 4.584

3.  Levels of evidence available for techniques in antireflux surgery.

Authors:  M Neufeld; A Graham
Journal:  Dis Esophagus       Date:  2007       Impact factor: 3.429

4.  A randomized controlled trial of laparoscopic nissen fundoplication versus proton pump inhibitors for treatment of patients with chronic gastroesophageal reflux disease: One-year follow-up.

Authors:  Mehran Anvari; Christopher Allen; John Marshall; David Armstrong; Ron Goeree; Wendy Ungar; Charles Goldsmith
Journal:  Surg Innov       Date:  2006-12       Impact factor: 2.058

5.  A research agenda for gastrointestinal and endoscopic surgery.

Authors:  D R Urbach; K D Horvath; N N Baxter; B A Jobe; A K Madan; A D Pryor; L Khaitan; A Torquati; S T Brower; T L Trus; S Schwaitzberg
Journal:  Surg Endosc       Date:  2007-02-08       Impact factor: 4.584

6.  Gastroesophageal reflux symptoms in a Danish population: a prospective follow-up analysis of symptoms, quality of life, and health-care use.

Authors:  Jane Møller Hansen; Mette Wildner-Christensen; Ove B Schaffalitzky de Muckadell
Journal:  Am J Gastroenterol       Date:  2009-07-21       Impact factor: 10.864

7.  Continued (5-year) followup of a randomized clinical study comparing antireflux surgery and omeprazole in gastroesophageal reflux disease.

Authors:  L Lundell; P Miettinen; H E Myrvold; S A Pedersen; B Liedman; J G Hatlebakk; R Julkonen; K Levander; J Carlsson; M Lamm; I Wiklund
Journal:  J Am Coll Surg       Date:  2001-02       Impact factor: 6.113

8.  Comparison of medical and surgical therapy for complicated gastroesophageal reflux disease in veterans. The Department of Veterans Affairs Gastroesophageal Reflux Disease Study Group.

Authors:  S J Spechler
Journal:  N Engl J Med       Date:  1992-03-19       Impact factor: 91.245

9.  Comparison of results from a randomized trial 1 year after laparoscopic Nissen and Toupet fundoplications.

Authors:  Oliver O Koch; Adolf Kaindlstorfer; Stavros A Antoniou; Ruzica Rosalia Luketina; Klaus Emmanuel; Rudolph Pointner
Journal:  Surg Endosc       Date:  2013-01-30       Impact factor: 4.584

10.  Comparing laparoscopic antireflux surgery with esomeprazole in the management of patients with chronic gastro-oesophageal reflux disease: a 3-year interim analysis of the LOTUS trial.

Authors:  L Lundell; S Attwood; C Ell; R Fiocca; J-P Galmiche; J Hatlebakk; T Lind; O Junghard
Journal:  Gut       Date:  2008-05-09       Impact factor: 23.059

View more
  21 in total

1.  Laparoscopic surgery: A qualified systematic review.

Authors:  Alexander Buia; Florian Stockhausen; Ernst Hanisch
Journal:  World J Methodol       Date:  2015-12-26

Review 2.  Laparoscopic augmentation of the diaphragmatic hiatus with biologic mesh versus suture repair: a systematic review and meta-analysis.

Authors:  Stavros A Antoniou; Beat P Müller-Stich; George A Antoniou; Gernot Köhler; Ruzica-Rosalia Luketina; Oliver O Koch; Rudolph Pointner; Frank-Alexander Granderath
Journal:  Langenbecks Arch Surg       Date:  2015-06-07       Impact factor: 3.445

3.  Outcome of laparoscopic Nissen fundoplication for gastroesophageal reflux disease in non-responders to proton pump inhibitors.

Authors:  Emad Hamdy; Ayman El Nakeeb; Hosam Hamed; Mohamed El Hemaly; Nabil Gad ElHak
Journal:  J Gastrointest Surg       Date:  2014-07-02       Impact factor: 3.452

4.  Laparoscopic Nissen Fundoplication Plus Mid-gastric Plication for Treatment of Obese Patients with Gastroesophageal Reflux Disease.

Authors:  Ahmed Talha; Mohammed Ibrahim
Journal:  Obes Surg       Date:  2018-02       Impact factor: 4.129

5.  Fundoplication versus medical management of gastroesophageal reflux disease: systematic review and meta-analysis.

Authors:  Eva Blozik
Journal:  Surg Endosc       Date:  2014-05-23       Impact factor: 4.584

6.  Commentary on "Rickenbacher et al. Fundoplication versus medical management of gastroesophageal reflux disease: systematic review and meta-analysis." Surg Endosc. doi: 10.1007/s00464-013-3140-z.

Authors:  Megan Lockwood; Erica Giraldi
Journal:  Surg Endosc       Date:  2014-01-11       Impact factor: 4.584

Review 7.  Diagnosis and treatment of gastroesophageal reflux disease.

Authors:  Raul Badillo; Dawn Francis
Journal:  World J Gastrointest Pharmacol Ther       Date:  2014-08-06

Review 8.  Surgical treatment of GERD: systematic review and meta-analysis.

Authors:  Sophia K McKinley; Rebecca C Dirks; Danielle Walsh; Celeste Hollands; Lauren E Arthur; Noe Rodriguez; Joyce Jhang; Ahmed Abou-Setta; Aurora Pryor; Dimitrios Stefanidis; Bethany J Slater
Journal:  Surg Endosc       Date:  2021-03-02       Impact factor: 4.584

Review 9.  Does anti-reflux surgery disrupt the pathway of Barrett's esophagus progression to cancer?

Authors:  Sebastian F Schoppmann; Ivan Kristo; Martin Riegler
Journal:  Transl Gastroenterol Hepatol       Date:  2018-12-05

10.  SAGES guidelines for the surgical treatment of gastroesophageal reflux (GERD).

Authors:  Bethany J Slater; Rebecca C Dirks; Sophia K McKinley; Mohammed T Ansari; Geoffrey P Kohn; Nirav Thosani; Bashar Qumseya; Sarah Billmeier; Shaun Daly; Catherine Crawford; Anne P Ehlers; Celeste Hollands; Francesco Palazzo; Noe Rodriguez; Arianne Train; Eelco Wassenaar; Danielle Walsh; Aurora D Pryor; Dimitrios Stefanidis
Journal:  Surg Endosc       Date:  2021-07-19       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.